Global Rhizobacteria 麻豆原创 Growth 2024-2030

Publication ID:

LPI11240357

Publication Date:

November 4, 2024

Pages:

106

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Organic Farming [2]

Agriculture [3]

Industry & Manufacturing [4]

Description:

Rhizobacteria are bacteria that live in the soil surrounding plant roots and form complex interactions with the roots. They can promote plant growth, enhance plant resistance to pathogens, and improve soil health.
The global Rhizobacteria market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淩hizobacteria Industry Forecast鈥� looks at past sales and reviews total world Rhizobacteria sales in 2023, providing a comprehensive analysis by region and market sector of projected Rhizobacteria sales for 2024 through 2030. With Rhizobacteria sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rhizobacteria industry.
This Insight Report provides a comprehensive analysis of the global Rhizobacteria landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rhizobacteria portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Rhizobacteria market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rhizobacteria and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rhizobacteria.
United States market for Rhizobacteria is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Rhizobacteria is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Rhizobacteria is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Rhizobacteria players cover Bayer, Basf, Qunlin Bio, Jocanima, Tonglu Huifeng Biotechnology, Zhejiang Province, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Rhizobacteria market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Beneficial
Harmful
Neutral
Segmentation by Application:
Nitrogen Fixation
Production of Plant Hormones
Disease Resistance
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Basf
Qunlin Bio
Jocanima
Tonglu Huifeng Biotechnology, Zhejiang Province
Kono
Tianhui
Agrilife
Real IPM
Yitai China
Novozymes
Lallemand Plant Care
Valent BioSciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rhizobacteria market?
What factors are driving Rhizobacteria market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rhizobacteria market opportunities vary by end market size?
How does Rhizobacteria break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Rhizobacteria Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Rhizobacteria by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Rhizobacteria by Country/Region, 2019, 2023 & 2030
2.2 Rhizobacteria Segment by Type
2.2.1 Beneficial
2.2.2 Harmful
2.2.3 Neutral
2.3 Rhizobacteria Sales by Type
2.3.1 Global Rhizobacteria Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Rhizobacteria Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Rhizobacteria Sale Price by Type (2019-2024)
2.4 Rhizobacteria Segment by Application
2.4.1 Nitrogen Fixation
2.4.2 Production of Plant Hormones
2.4.3 Disease Resistance
2.4.4 Other
2.5 Rhizobacteria Sales by Application
2.5.1 Global Rhizobacteria Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Rhizobacteria Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Rhizobacteria Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Rhizobacteria Breakdown Data by Company
3.1.1 Global Rhizobacteria Annual Sales by Company (2019-2024)
3.1.2 Global Rhizobacteria Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Rhizobacteria Annual Revenue by Company (2019-2024)
3.2.1 Global Rhizobacteria Revenue by Company (2019-2024)
3.2.2 Global Rhizobacteria Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Rhizobacteria Sale Price by Company
3.4 Key Manufacturers Rhizobacteria Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rhizobacteria Product Location Distribution
3.4.2 Players Rhizobacteria Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Rhizobacteria by Geographic Region
4.1 World Historic Rhizobacteria 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Rhizobacteria Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Rhizobacteria Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Rhizobacteria 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Rhizobacteria Annual Sales by Country/Region (2019-2024)
4.2.2 Global Rhizobacteria Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rhizobacteria Sales Growth
4.4 APAC Rhizobacteria Sales Growth
4.5 Europe Rhizobacteria Sales Growth
4.6 Middle East & Africa Rhizobacteria Sales Growth
5 Americas
5.1 Americas Rhizobacteria Sales by Country
5.1.1 Americas Rhizobacteria Sales by Country (2019-2024)
5.1.2 Americas Rhizobacteria Revenue by Country (2019-2024)
5.2 Americas Rhizobacteria Sales by Type (2019-2024)
5.3 Americas Rhizobacteria Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rhizobacteria Sales by Region
6.1.1 APAC Rhizobacteria Sales by Region (2019-2024)
6.1.2 APAC Rhizobacteria Revenue by Region (2019-2024)
6.2 APAC Rhizobacteria Sales by Type (2019-2024)
6.3 APAC Rhizobacteria Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rhizobacteria by Country
7.1.1 Europe Rhizobacteria Sales by Country (2019-2024)
7.1.2 Europe Rhizobacteria Revenue by Country (2019-2024)
7.2 Europe Rhizobacteria Sales by Type (2019-2024)
7.3 Europe Rhizobacteria Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rhizobacteria by Country
8.1.1 Middle East & Africa Rhizobacteria Sales by Country (2019-2024)
8.1.2 Middle East & Africa Rhizobacteria Revenue by Country (2019-2024)
8.2 Middle East & Africa Rhizobacteria Sales by Type (2019-2024)
8.3 Middle East & Africa Rhizobacteria Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rhizobacteria
10.3 Manufacturing Process Analysis of Rhizobacteria
10.4 Industry Chain Structure of Rhizobacteria
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rhizobacteria Distributors
11.3 Rhizobacteria Customer
12 World Forecast Review for Rhizobacteria by Geographic Region
12.1 Global Rhizobacteria 麻豆原创 Size Forecast by Region
12.1.1 Global Rhizobacteria Forecast by Region (2025-2030)
12.1.2 Global Rhizobacteria Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Rhizobacteria Forecast by Type (2025-2030)
12.7 Global Rhizobacteria Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Rhizobacteria Product Portfolios and Specifications
13.1.3 Bayer Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Basf
13.2.1 Basf Company Information
13.2.2 Basf Rhizobacteria Product Portfolios and Specifications
13.2.3 Basf Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Basf Main Business Overview
13.2.5 Basf Latest Developments
13.3 Qunlin Bio
13.3.1 Qunlin Bio Company Information
13.3.2 Qunlin Bio Rhizobacteria Product Portfolios and Specifications
13.3.3 Qunlin Bio Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Qunlin Bio Main Business Overview
13.3.5 Qunlin Bio Latest Developments
13.4 Jocanima
13.4.1 Jocanima Company Information
13.4.2 Jocanima Rhizobacteria Product Portfolios and Specifications
13.4.3 Jocanima Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Jocanima Main Business Overview
13.4.5 Jocanima Latest Developments
13.5 Tonglu Huifeng Biotechnology, Zhejiang Province
13.5.1 Tonglu Huifeng Biotechnology, Zhejiang Province Company Information
13.5.2 Tonglu Huifeng Biotechnology, Zhejiang Province Rhizobacteria Product Portfolios and Specifications
13.5.3 Tonglu Huifeng Biotechnology, Zhejiang Province Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Tonglu Huifeng Biotechnology, Zhejiang Province Main Business Overview
13.5.5 Tonglu Huifeng Biotechnology, Zhejiang Province Latest Developments
13.6 Kono
13.6.1 Kono Company Information
13.6.2 Kono Rhizobacteria Product Portfolios and Specifications
13.6.3 Kono Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kono Main Business Overview
13.6.5 Kono Latest Developments
13.7 Tianhui
13.7.1 Tianhui Company Information
13.7.2 Tianhui Rhizobacteria Product Portfolios and Specifications
13.7.3 Tianhui Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Tianhui Main Business Overview
13.7.5 Tianhui Latest Developments
13.8 Agrilife
13.8.1 Agrilife Company Information
13.8.2 Agrilife Rhizobacteria Product Portfolios and Specifications
13.8.3 Agrilife Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Agrilife Main Business Overview
13.8.5 Agrilife Latest Developments
13.9 Real IPM
13.9.1 Real IPM Company Information
13.9.2 Real IPM Rhizobacteria Product Portfolios and Specifications
13.9.3 Real IPM Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Real IPM Main Business Overview
13.9.5 Real IPM Latest Developments
13.10 Yitai China
13.10.1 Yitai China Company Information
13.10.2 Yitai China Rhizobacteria Product Portfolios and Specifications
13.10.3 Yitai China Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Yitai China Main Business Overview
13.10.5 Yitai China Latest Developments
13.11 Novozymes
13.11.1 Novozymes Company Information
13.11.2 Novozymes Rhizobacteria Product Portfolios and Specifications
13.11.3 Novozymes Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Novozymes Main Business Overview
13.11.5 Novozymes Latest Developments
13.12 Lallemand Plant Care
13.12.1 Lallemand Plant Care Company Information
13.12.2 Lallemand Plant Care Rhizobacteria Product Portfolios and Specifications
13.12.3 Lallemand Plant Care Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Lallemand Plant Care Main Business Overview
13.12.5 Lallemand Plant Care Latest Developments
13.13 Valent BioSciences
13.13.1 Valent BioSciences Company Information
13.13.2 Valent BioSciences Rhizobacteria Product Portfolios and Specifications
13.13.3 Valent BioSciences Rhizobacteria Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Valent BioSciences Main Business Overview
13.13.5 Valent BioSciences Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.